News articles about Petiq (NASDAQ:PETQ) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Petiq earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.6442189124378 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

A number of research analysts have commented on PETQ shares. Jefferies Group LLC started coverage on shares of Petiq in a research note on Tuesday, August 15th. They set a “hold” rating and a $25.00 price target for the company. William Blair started coverage on shares of Petiq in a research note on Tuesday, August 15th. They set an “outperform” rating for the company. SunTrust Banks, Inc. started coverage on shares of Petiq in a research note on Tuesday, August 15th. They set a “buy” rating and a $28.00 price target for the company. Oppenheimer Holdings, Inc. started coverage on shares of Petiq in a research note on Tuesday, August 15th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Raymond James Financial, Inc. started coverage on shares of Petiq in a report on Tuesday, August 15th. They set an “outperform” rating and a $26.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Petiq presently has a consensus rating of “Buy” and an average price target of $27.00.

Petiq (NASDAQ PETQ) traded up 0.93% during mid-day trading on Thursday, hitting $25.06. 204,439 shares of the stock traded hands. The firm’s 50-day moving average price is $26.89 and its 200-day moving average price is $26.89. Petiq has a 52 week low of $19.76 and a 52 week high of $26.99. The firm’s market cap is $331.37 million.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-petiq-petq-share-price/1534842.html.

About Petiq

PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.

Receive News & Ratings for Petiq Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petiq Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.